These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 36806352)

  • 21. The C5a/C5aR1 axis promotes progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia/reperfusion injury.
    Peng Q; Wu W; Wu KY; Cao B; Qiang C; Li K; Sacks SH; Zhou W
    Kidney Int; 2019 Jul; 96(1):117-128. PubMed ID: 31029505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C5aR2 receptor: The genomic twin of the flamboyant C5aR1.
    Das A; Gupta PK; Rana S
    J Cell Biochem; 2022 Nov; 123(11):1841-1856. PubMed ID: 35977039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C5a-C5aR1 Axis Activation Drives Envenomation Immunopathology by the Snake
    Silva de França F; Villas-Boas IM; Cogliati B; Woodruff TM; Reis EDS; Lambris JD; Tambourgi DV
    Front Immunol; 2021; 12():652242. PubMed ID: 33936074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular basis of anaphylatoxin binding, activation, and signaling bias at complement receptors.
    Yadav MK; Maharana J; Yadav R; Saha S; Sarma P; Soni C; Singh V; Saha S; Ganguly M; Li XX; Mohapatra S; Mishra S; Khant HA; Chami M; Woodruff TM; Banerjee R; Shukla AK; Gati C
    Cell; 2023 Oct; 186(22):4956-4973.e21. PubMed ID: 37852260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential expression of C5aR1 and C5aR2 in innate and adaptive immune cells located in early skin lesions of bullous pemphigoid patients.
    Emtenani S; Holtsche MM; Stahlkopf R; Seiler DL; Burn T; Liu H; Parker M; Yilmaz K; Dikmen HO; Lang MH; Sadik CD; Karsten CM; van Beek N; Ludwig RJ; Köhl J; Schmidt E
    Front Immunol; 2022; 13():942493. PubMed ID: 36466856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1
    Wang HA; Lee JD; Lee KM; Woodruff TM; Noakes PG
    Skelet Muscle; 2017 Jun; 7(1):10. PubMed ID: 28571586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion of Biliverdin Reductase A in Myeloid Cells Promotes Chemokine Expression and Chemotaxis in Part via a Complement C5a--C5aR1 Pathway.
    Bisht K; Canesin G; Cheytan T; Li M; Nemeth Z; Csizmadia E; Woodruff TM; Stec DE; Bulmer AC; Otterbein LE; Wegiel B
    J Immunol; 2019 May; 202(10):2982-2990. PubMed ID: 30952817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C5a-C5AR1 axis as a potential trigger of the rupture of intracranial aneurysms.
    Okada A; Shimizu K; Kawashima A; Kayahara T; Itani M; Kurita H; Miyamoto S; Kataoka H; Aoki T
    Sci Rep; 2024 Feb; 14(1):3105. PubMed ID: 38326494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.
    Colley CS; Popovic B; Sridharan S; Debreczeni JE; Hargeaves D; Fung M; An LL; Edwards B; Arnold J; England E; Eghobamien L; Sivars U; Flavell L; Renshaw J; Wickson K; Warrener P; Zha J; Bonnell J; Woods R; Wilkinson T; Dobson C; Vaughan TJ
    MAbs; 2018 Jan; 10(1):104-117. PubMed ID: 28952876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The C5a/C5a receptor 1 axis controls tissue neovascularization through CXCL4 release from platelets.
    Nording H; Baron L; Haberthür D; Emschermann F; Mezger M; Sauter M; Sauter R; Patzelt J; Knoepp K; Nording A; Meusel M; Meyer-Saraei R; Hlushchuk R; Sedding D; Borst O; Eitel I; Karsten CM; Feil R; Pichler B; Erdmann J; Verschoor A; Chavakis E; Chavakis T; von Hundelshausen P; Köhl J; Gawaz M; Langer HF
    Nat Commun; 2021 Jun; 12(1):3352. PubMed ID: 34099640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727.
    Robertson N; Rappas M; Doré AS; Brown J; Bottegoni G; Koglin M; Cansfield J; Jazayeri A; Cooke RM; Marshall FH
    Nature; 2018 Jan; 553(7686):111-114. PubMed ID: 29300009
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The C5a/C5aR1 axis controls the development of experimental allergic asthma independent of LysM-expressing pulmonary immune cells.
    Wiese AV; Ender F; Quell KM; Antoniou K; Vollbrandt T; König P; Köhl J; Laumonnier Y
    PLoS One; 2017; 12(9):e0184956. PubMed ID: 28931049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Netrin-1 Reduces Monocyte and Macrophage Chemotaxis towards the Complement Component C5a.
    Taylor L; Brodermann MH; McCaffary D; Iqbal AJ; Greaves DR
    PLoS One; 2016; 11(8):e0160685. PubMed ID: 27509208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. C5a/C5aR1 Pathway Is Critical for the Pathogenesis of Psoriasis.
    Zheng QY; Liang SJ; Xu F; Li GQ; Luo N; Wu S; Li Y; Tang M; Zhong Y; Chen J; Yang D; Sun DD; Zhang KQ; Xu GL
    Front Immunol; 2019; 10():1866. PubMed ID: 31447855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anaphylatoxin C5a: Structure, function, signaling, physiology, disease, and therapeutics.
    Ghosh M; Rana S
    Int Immunopharmacol; 2023 May; 118():110081. PubMed ID: 36989901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelets promote CRC by activating the C5a/C5aR1 axis via PSGL-1/JNK/STAT1 signaling in tumor-associated macrophages.
    Li X; Chen X; Gong S; Zhao J; Yao C; Zhu H; Xiao R; Qin Y; Li R; Sun N; Li X; Dong F; Zhao T; Pan Y; Yang J
    Theranostics; 2023; 13(6):2040-2056. PubMed ID: 37064877
    [No Abstract]   [Full Text] [Related]  

  • 37. Osteoblast-specific overexpression of complement receptor C5aR1 impairs fracture healing.
    Bergdolt S; Kovtun A; Hägele Y; Liedert A; Schinke T; Amling M; Huber-Lang M; Ignatius A
    PLoS One; 2017; 12(6):e0179512. PubMed ID: 28614388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C5a receptor1 inhibition alleviates influenza virus-induced acute lung injury.
    Song N; Li P; Jiang Y; Sun H; Cui J; Zhao G; Li D; Guo Y; Chen Y; Gao J; Sun S; Zhou Y
    Int Immunopharmacol; 2018 Jun; 59():12-20. PubMed ID: 29621732
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutraligands of C5a can potentially occlude the interaction of C5a with the complement receptors C5aR1 and C5aR2.
    Das A; Ghosh M; Gupta PK; Rana S
    J Cell Biochem; 2023 Feb; 124(2):266-281. PubMed ID: 36565188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement C5a Receptor Signaling Alters Stress Responsiveness and Modulates Microglia Following Chronic Stress Exposure.
    Chen HC; Spiers JG; Lerskiatiphanich T; Parker SE; Lavidis NA; Fung JN; Woodruff TM; Lee JD
    Biol Psychiatry Glob Open Sci; 2024 May; 4(3):100306. PubMed ID: 38628385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.